Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Immunobiology

• Publication date

  2014-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.imbio.2013.08.008PMID 24054942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles.

  2013cited by this paper
• Secretory expression and efficient purification of recombinant anthrax toxin lethal factor with full biological activity in E. coli.

  2013cited by this paper
• Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein

  2012cited by this paper
• Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

  2012cited by this paper
• Construction and Characterization of Virus-Like Particles: A Review

  2012cited by this paper
• SplitCore: An exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure

  2011cited by this paper
• Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris.

  2011cited by this paper
• Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments

  2009cited by this paper
• Advances in the development of next-generation anthrax vaccines.

  2009cited by this paper
• Use of hepadnavirus core proteins as vaccine platforms

  2009cited by this paper
• Phase I Trial of an Alhydrogel Adjuvanted Hepatitis B Core Virus-Like Particle Containing Epitopes of Plasmodium falciparum Circumsporozoite Protein

  2008cited by this paper
• Subcellular localization of Hepatitis B virus core protein expressed from two diff erent constructs in the Semliki Forest virus expression system

  2008cited by this paper
• Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.

  2008cited by this paper
• Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.

  2008cited by this paper
• Advantages to the use of rodent hepadnavirus core proteins as vaccine platforms.

  2007cited by this paper
• Anthrax toxin: receptor binding, internalization, pore formation, and translocation.

  2007cited by this paper
• The 2beta2-2beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope.

  2006cited by this paper
• The 2β2–2β3 loop of anthrax protective antigen contains a dominant neutralizing epitope

  2006cited by this paper
• The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling

  2006cited by this paper
• Safety and Enhanced Immunogenicity of a Hepatitis B Core Particle Plasmodium falciparum Malaria Vaccine Formulated in Adjuvant Montanide ISA 720 in a Phase I Trial

  2005cited by this paper
• A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies.

  2005cited by this paper
• Combinatorial Approach to Hepadnavirus-Like Particle Vaccine Design

  2005cited by this paper
• Comparative Antigenicity and Immunogenicity of Hepadnavirus Core Proteins

  2005cited by this paper
• A "universal" human influenza A vaccine.

  2004cited by this paper
• Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen

  2004cited by this paper
• Phase I Testing of a Malaria Vaccine Composed of Hepatitis B Virus Core Particles Expressing Plasmodium falciparum Circumsporozoite Epitopes

  2004cited by this paper
• SWISS-MODEL: an automated protein homology-modeling server

  2003cited by this paper
• Anthrax toxin.

  2003cited by this paper
• HBV Core Particles as a Carrier for B Cell/T Cell Epitopes

  2001cited by this paper
• Anthrax Toxin

  2001cited by this paper
• Insertion of foreign epitopes in HBcAg: how to make the chimeric particle assemble

  2000cited by this paper
• A universal influenza A vaccine based on the extracellular domain of the M2 protein

  1999cited by this paper
• The crystal structure of the human hepatitis B virus capsid.

  1999cited by this paper
• Core particles of hepatitis B virus as carrier for foreign epitopes.

  1998cited by this paper
• Crystal structure of the anthrax toxin protective antigen

  1997cited by this paper
• SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling

  1997cited by this paper
• Role of B cells in antigen presentation of the hepatitis B core.

  1997cited by this paper
• A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids

  1989cited by this paper

• Human anthrax vaccines: Current status and future prospects

  2025cites this paper
• Human adenovirus type 7 virus-like particle vaccine induces Dendritic cell maturation through the TLR4/NF-κB pathway and is highly immunogenic.

  2023cites this paper
• Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of Toxoplasma gondii Against Acute and Chronic Toxoplasmosis in Mice

  2019cites this paper
• Polysaccharide PCP-I isolated from Poria cocos enhances the immunogenicity and protection of an anthrax protective antigen-based vaccine

  2019cites this paper
• Self-conjugated protective antigen elicits strong and durable protective antibody response against anthrax.

  2019cites this paper
• Synthetic biology for bioengineering virus‐like particle vaccines

  2018cites this paper
• Epitope selection and their placement for increased virus neutralization in a novel vaccination strategy for porcine epidemic diarrhea virus utilizing the Hepatitis B virus core antigen

  2018cites this paper
• A Dual Bioconjugated Virus-Like Nanoparticle as a Drug Delivery System and Comparison with a pH-Responsive Delivery System

  2018cites this paper
• Vaccine Development Against Porcine Epidemic Diarrhea Virus Utilizing the Hepatitis B Virus Core Antigen Protein

  2018cites this paper
• Development of plant-produced protein body vaccine candidates for bluetongue virus

  2017cites this paper
• Hepatitis B core antigen based novel vaccine against porcine epidemic diarrhea virus.

  2017cites this paper
• Virus-like particles as a novel platform for delivery of protective Burkholderia antigens

  2016cites this paper
• The true story and advantages of the famous Hepatitis B virus core particles: Outlook 2016

  2016cites this paper
• Construction , expression and purification of recombinant HBcAg-MAGE-A 3 therapeutic cancer vaccine

  2016cites this paper
• Neutralizing antibody and functional mapping of Bacillus anthracis protective antigen-The first step toward a rationally designed anthrax vaccine.

  2016cites this paper
• Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R

  2016cites this paper
• Design and Testing of Novel Anthrax Vaccines Utilizing a Tobacco Mosaic Virus Expression System

  2015cites this paper
• Anthrax lethal and edema toxins in anthrax pathogenesis.

  2014cites this paper